Longitudinal assessments of quality of life and late toxicities before and after definitive chemoradiation for esophageal cancer

Japanese Journal of Clinical Oncology

Volumn 44, Issue 1, 2014, Pages 78-84

  Yamashita, Hideomi ^a   Omori, Mami ^a   Okuma, Kae ^a   Kobayashi, Reiko ^a   Igaki, Hiroshi ^a   Nakagawa, Keiichi ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

Chemoradiation; Combined modality treatment; Esophageal cancer; FACT E; Quality of life

Indexed keywords

FLUOROURACIL; NEDAPLATIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PAIN; CHEMORADIOTHERAPY; DYSPNEA; ESOPHAGUS CANCER; EXTERNAL BEAM RADIOTHERAPY; FATIGUE; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; FUNCTIONAL ASSESSMENT OF CANCER THERAPY ESOPHAGEAL SCORING; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; OVERALL SURVIVAL; QUALITY OF LIFE; QUESTIONNAIRE; RADIATION INJURY; SCORING SYSTEM;

EID: 84892468941     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyt170     Document Type: Article

References (17)

1. Vistad I, Cvancarova M, Fossa SD, et al. Postradiotherapy morbidity in long-term survivors after locally advanced cervical cancer: how well do physicians' assessments agree with those of their patients? Int J Radiat Oncol Biol Phys 2008;71:1335-42.
2. Darling G, Eton D, Sulman J, Casson A, Cella D. Validation of the functional assessment of cancer therapy esophageal cancer subscale. Cancer 2006;107:854-63.
3. Kachnic LA, Winter K, Wasserman T, et al. Longitudinal quality-of-life analysis of RTOG 94-05 (Int 0123): a phase III trial of definitive chemoradiotherapy for esophageal cancer. Gastrointest Cancer Res 2011;4:45-52.
4. The Japanese Society for Esophageal Diseases. Comprehensive Registry of Esophageal Cancer in Japan (1998, 1999)&Long-Term Result of Esophagectomy in Japan (1988-1997). Tokyo: The Japanese Society of Esophageal Diseases 2002.
5. Yamashita H, Nakagawa K, Tago M, et al. Radiation therapy combined with cis-diammine-glycolatoplatinum (nedaplatin) and 5-fluorouracil for Japanese stage II-IV esophageal cancer compared with cisplatin plus 5-fluorouracil regimen: a retrospective study. Dis Esophagus 2006;19:15-9.
6. Yamashita H, Okuma K, Wakui R, et al. Details of recurrence sites after elective nodal irradiation (ENI) using 3D-conformal radiotherapy (3D-CRT) combined with chemotherapy for thoracic esophageal squamous cell carcinoma-a retrospective analysis. Radiother Oncol 2011;98:255-60.
7. Yoshioka T, GamohM, Shineha R, et al. A new combination chemotherapy with cis-diammine-glycolatoplatinum (Nedaplatin) and 5-fluorouracil for advanced esophageal cancers. Intern Med 1999;38:844-8.
8. Minsky BD, Pajak TF, Ginsberg RJ, et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 2002;20:1167-74.
9. Crosby T, Hurt CN, Falk S, et al. Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial. Lancet Oncol 2013;14:627-37.
10. Brooks JA, Kesler KA, Johnson CS, Ciatta D, Brown JW. Prospective analysis of quality of life after surgical resection for esophageal cancer: preliminary results. J Surg Oncol 2002;81:185-94.
11. Safieddine N, Xu W, Quadri SM, et al. Health-related quality of life in esophageal cancer: effect of neoadjuvant chemoradiotherapy followed by surgical intervention. J Thorac Cardiovasc Surg 2009;137:36-42.
12. Bonnetain F, Bouche O, Michel P, et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Ann Oncol 2006;17:827-34.
13. Blazeby JM, Farndon JR, Donovan J, Alderson D. A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma. Cancer 2000;88:1781-7.
14. Fang FM, Tsai WL, Chiu HC, Kuo WR, Hsiung CY. Quality of life as a survival predictor for esophageal squamous cell carcinoma treated with radiotherapy. Int J Radiat Oncol 2004;58:1394-404.
15. Bedenne L, Michel P, Bouché O, et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 2007;25:1160-8.
16. Chiu PW, Chan AC, Leung SF, et al. Multicenter prospective randomized trial comparing standard esophagectomy with chemoradiotherapy for treatment of squamous esophageal cancer: early results from the Chinese University Research Group for Esophageal Cancer (CURE). J Gastrointest Surg 2005;9:794-802.
17. Bonnetain F, Bouché O, Michel P, et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Ann Oncol 2006;17:827-34.